Uk Export Advice

42 - China Life Sciences Cooperation Opportunities



China is going through a healthcare revolution as the population becomes more affluent, lives longer and has greater expectations of what healthcare provision they should receive. The Chinese government is focusing on innovation as the way to solve the nation’s most pressing healthcare problems and is investing heavily in research and development and international partnerships. My name is David James and in this episode of UK Export Advice I’m talking to Qionger He, a former scientist at GSK who now works for the Department for International Trade in their Life Sciences team based in China. Qionger explains the huge opportunities for British life sciences businesses to get Chinese investment, work on joint ventures and accelerate their trials to gain global clinical acceptance. My name is David James and I would just like to say thank you for taking the time to listen to this episode. If you would like to get in touch with the Qionger or anyone else at the Department for International Trade’s life sciences